pharmarch.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
User-agent: * Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php Sitemap: https://www.pharmarch.com/wp-sitemap.xml Sitemap:
Meta Tags
Title Pharmaceutics, Medicines and Health Topics |
Description PharmArch.com is a blog cares about pharmaceutical, medicine and health.Main topic is about the import and export business of pharmaceutical, medical and health
Keywords health blog, pharmaceutical blog, pharma blog
Server Information
WebSite pharmarch faviconpharmarch.com
Host IP 149.129.62.236
Location Malaysia
Related Websites
Site Rank
More to Explore
pharmarch.com Valuation
US$1,181,842
Last updated: 2023-05-07 14:06:58

pharmarch.com has Semrush global rank of 8,955,772. pharmarch.com has an estimated worth of US$ 1,181,842, based on its estimated Ads revenue. pharmarch.com receives approximately 136,367 unique visitors each day. Its web server is located in Malaysia, with IP address 149.129.62.236. According to SiteAdvisor, pharmarch.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$1,181,842
Daily Ads Revenue US$1,091
Monthly Ads Revenue US$32,728
Yearly Ads Revenue US$392,736
Daily Unique Visitors 9,092
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
pharmarch.com. A 598 IP: 149.129.62.236
pharmarch.com. NS 86400 NS Record: dns28.hichina.com.
pharmarch.com. NS 86400 NS Record: dns27.hichina.com.
pharmarch.com. TXT 600 TXT Record: google-site-verification=dzGI--sjqx3ceIm3B9-PwwH3F31ueNLdOIqNy32L5gc
HtmlToTextCheckTime:2023-05-07 14:06:58
HOME Medicines Quality Control & Quality Assurance APIs Companies Health Special Topics Special Topics PharmArch - About Pharmaceutical, Medicine & Health More Topics HPLC WHO Prequalification COVID-19 Companies InnoCare’s ICP-248 completes the first subject administration in clinical trail On March 10th, 2023, Beijing InnoCare announced that its independently developed BCL2 inhibitor ICP-248 completed the first subject administration in China. ICP-248 is a new oral highly selective BCL2 inhibitor independently developed by InnoCare. It is intended for the treatment of malignant hematological tumors such as non-Hodgkin’s lymphoma (NHL) and acute lymphoblastic leukemia (ALL) as a monotherapy or in combination with other drugs such as BTK inhibitors. ICP-248 is currently being investigated for B-cell malignancies, malignant hematologic tumors, and hematologic tumors. BCL2 is an oncogene with a significant role in… 2023-03-24 Health 10 Antibiotics with Infusion Time More Than 60 Minutes
Ads.txtCheckTime:2023-05-07 14:06:58
google.com, pub-8681724370883720, DIRECT,
HTTP Headers
HTTP/1.1 301 Moved Permanently
Server: nginx
Date: Thu, 28 Oct 2021 04:35:18 GMT
Content-Type: text/html; charset=UTF-8
Connection: keep-alive
Set-Cookie: session_prefix=f81dfd3e91d4d3561cf5f39ae68fd9cf; expires=Sun, 26-Oct-2031 04:35:18 GMT; Max-Age=315360000; path=/; HttpOnly
X-Redirect-By: WordPress
Location: http://www.pharmarch.com/

HTTP/1.1 200 OK
Server: nginx
Date: Thu, 28 Oct 2021 04:35:19 GMT
Content-Type: text/html; charset=UTF-8
Connection: keep-alive
Vary: Accept-Encoding
Set-Cookie: session_prefix=0ab6fab817732144a87804e027c992ec; expires=Sun, 26-Oct-2031 04:35:19 GMT; Max-Age=315360000; path=/; HttpOnly
Link: ; rel="https://api.w.org/"
pharmarch.com Whois Information
Domain Name: PHARMARCH.COM
Registry Domain ID: 2592673588_DOMAIN_COM-VRSN
Registrar WHOIS Server: grs-whois.hichina.com
Registrar URL: http://www.net.cn
Updated Date: 2021-02-20T08:05:51Z
Creation Date: 2021-02-20T08:04:30Z
Registry Expiry Date: 2023-02-20T08:04:30Z
Registrar: Alibaba Cloud Computing (Beijing) Co., Ltd.
Registrar IANA ID: 420
Registrar Abuse Contact Email: DomainAbuse@service.aliyun.com
Registrar Abuse Contact Phone: +86.95187
Domain Status: ok https://icann.org/epp#ok
Name Server: DNS27.HICHINA.COM
Name Server: DNS28.HICHINA.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-15T22:19:22Z <<<